Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Minority Interest (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Minority Interest for 9 consecutive years, with $21.0 million as the latest value for Q1 2026.

  • For Q1 2026, Minority Interest fell 93.4% year-over-year to $21.0 million; the TTM value through Mar 2026 reached $21.0 million, down 93.4%, while the annual FY2025 figure was $311.3 million, 1.89% up from the prior year.
  • Minority Interest hit $21.0 million in Q1 2026 for Select Medical Holdings, down from $311.3 million in the prior quarter.
  • Across five years, Minority Interest topped out at $317.6 million in Q1 2025 and bottomed at $8.5 million in Q2 2025.
  • Average Minority Interest over 5 years is $92.2 million, with a median of $34.0 million recorded in 2022.
  • Year-over-year, Minority Interest tumbled 94.65% in 2022 and then skyrocketed 1022.74% in 2025.
  • Select Medical Holdings' Minority Interest stood at $34.0 million in 2022, then skyrocketed by 662.02% to $259.4 million in 2023, then grew by 17.79% to $305.6 million in 2024, then rose by 1.89% to $311.3 million in 2025, then tumbled by 93.27% to $21.0 million in 2026.
  • According to Business Quant data, Minority Interest over the past three periods came in at $21.0 million, $311.3 million, and $8.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.